Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis


Journal article


A. Flores, N. Hosseini-Nassab, K. Jarr, J. Ye, X. Zhu, R. Wirka, A. Koh, P. Tsantilas, Y. Wang, V. Nanda, Y. Kojima, Y. Zeng, M. Lotfi, R. Sinclair, I. Weissman, E. Ingelsson, B. Smith, N. Leeper
Nature Nanotechnology, 2020

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Flores, A., Hosseini-Nassab, N., Jarr, K., Ye, J., Zhu, X., Wirka, R., … Leeper, N. (2020). Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nature Nanotechnology.


Chicago/Turabian   Click to copy
Flores, A., N. Hosseini-Nassab, K. Jarr, J. Ye, X. Zhu, R. Wirka, A. Koh, et al. “Pro-Efferocytic Nanoparticles Are Specifically Taken up by Lesional Macrophages and Prevent Atherosclerosis.” Nature Nanotechnology (2020).


MLA   Click to copy
Flores, A., et al. “Pro-Efferocytic Nanoparticles Are Specifically Taken up by Lesional Macrophages and Prevent Atherosclerosis.” Nature Nanotechnology, 2020.


BibTeX   Click to copy

@article{a2020a,
  title = {Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis},
  year = {2020},
  journal = {Nature Nanotechnology},
  author = {Flores, A. and Hosseini-Nassab, N. and Jarr, K. and Ye, J. and Zhu, X. and Wirka, R. and Koh, A. and Tsantilas, P. and Wang, Y. and Nanda, V. and Kojima, Y. and Zeng, Y. and Lotfi, M. and Sinclair, R. and Weissman, I. and Ingelsson, E. and Smith, B. and Leeper, N.}
}